25 May 2013
Keywords: lamictal, approval, lennox-gastaut, glaxo, wellcome, lamotrigine, been
Article | 01 September 1998
Glaxo Wellcome's Lamictal (lamotrigine) has been approved as add-ontherapy by the US Food and Drug Administration for the additional indication ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.